Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -8.93 Million AUD | -46.14% |
| 2023 | -6.11 Million AUD | -68.01% |
| 2022 | -3.63 Million AUD | 6.02% |
| 2021 | -3.87 Million AUD | -71.68% |
| 2020 | -2.25 Million AUD | -16.35% |
| 2019 | -1.93 Million AUD | 60.8% |
| 2018 | -4.94 Million AUD | 44.61% |
| 2017 | -8.93 Million AUD | -32.45% |
| 2016 | -4.37 Million AUD | -73.74% |
| 2015 | -3.88 Million AUD | -53.58% |
| 2014 | -2.52 Million AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.56 Million AUD | -537.91% |
| 2024 FY | - AUD | -46.14% |
| 2024 Q1 | -559.1 Thousand AUD | 79.68% |
| 2024 Q4 | -5.37 Million AUD | 0.0% |
| 2023 FY | - AUD | -68.01% |
| 2023 Q2 | -4.64 Million AUD | -222.85% |
| 2023 Q3 | -1.68 Million AUD | 63.83% |
| 2023 Q4 | -2.75 Million AUD | -63.66% |
| 2023 Q1 | -1.44 Million AUD | 59.32% |
| 2022 Q4 | -3.54 Million AUD | 0.0% |
| 2022 FY | - AUD | 6.02% |
| 2022 Q2 | -2.08 Million AUD | 0.0% |
| 2021 Q4 | -2.44 Million AUD | 0.0% |
| 2021 Q2 | -1.42 Million AUD | 0.0% |
| 2021 FY | - AUD | -71.68% |
| 2020 Q4 | -1.36 Million AUD | 0.0% |
| 2020 FY | - AUD | -16.35% |
| 2020 Q2 | -888.54 Thousand AUD | 0.0% |
| 2019 FY | - AUD | 60.8% |
| 2018 FY | - AUD | 44.61% |
| 2017 FY | - AUD | -32.45% |
| 2016 FY | - AUD | -73.74% |
| 2015 FY | - AUD | -53.58% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 87.42% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -50.73% |
| SQZ Biotechnologies Company | -64.14 Million USD | 86.067% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 48.551% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 109.503% |
| Mesoblast Limited | -62.38 Million USD | 85.676% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -481.796% |
| Genus plc | 73.7 Million USD | 112.126% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -35.168% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -151.95% |
| Marizyme, Inc. | -34.28 Million USD | 73.931% |
| ContraFect Corporation | -64.99 Million USD | 86.251% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -1.877% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -97.443% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -537.51% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -237.941% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -284.568% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -1625.073% |
| Accustem Sciences Inc. | -3.74 Million USD | -138.539% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 81.47% |
| EV Biologics, Inc. | -1.26 Million USD | -605.267% |
| Q BioMed Inc. | -617.62 Thousand USD | -1346.934% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 350.187% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1313.122% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -291.189% |
| Biomind Labs Inc. | -1.03 Million USD | -763.823% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 190.48% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -24.792% |
| Skye Bioscience, Inc. | -13.54 Million USD | 34.035% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -500.82% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -35646.68% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -130.07% |
| IMV Inc. | -35.52 Million USD | 74.843% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 43.687% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -257.186% |
| GB Sciences, Inc. | -1.41 Million USD | -529.394% |
| Alpha Cognition Inc. | -9.7 Million USD | 7.923% |
| HST Global, Inc. | -5303.00 USD | -168421.026% |
| CSL Limited | 4.78 Billion USD | 100.187% |
| Halberd Corporation | -74.27 Thousand USD | -11931.22% |
| Enzolytics Inc. | -2.12 Million USD | -321.138% |
| Resverlogix Corp. | -11.74 Million USD | 23.891% |
| Affymax, Inc. | -14.29 Million USD | 37.484% |
| SYBLEU INC | -141.57 Thousand USD | -6212.5% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -191.76% |
| argenx SE | -216.02 Million USD | 95.863% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 83.851% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 834.32% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -496.213% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 2458.931% |
| AVAX Technologies, Inc. | -6.11 Million USD | -46.2% |
| Zenith Capital Corp. | -8.6 Million USD | -3.842% |
| Genscript Biotech Corporation | -248.71 Million USD | 96.407% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -51198.261% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -265.29% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -4976.951% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 77.454% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -208.979% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -754.111% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 133007.049% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -410.667% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -365.231% |
| BioStem Technologies, Inc. | -7.55 Million USD | -18.309% |
| ONE Bio Corp. | 13.61 Million USD | 165.648% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -4834.987% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -334.452% |
| Agentix Corp. | -1.37 Million USD | -551.477% |
| LadRx Corporation | 412.28 Thousand USD | 2267.606% |
| Cell Source, Inc. | -4.27 Million USD | -109.166% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -2333.594% |
| Regen BioPharma, Inc. | 1.46 Million USD | 709.614% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -853.805% |
| NovAccess Global Inc. | -1.03 Million USD | -763.616% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 200.936% |
| Itoco Inc. | -1.86 Million USD | -378.154% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -2254.109% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -700.777% |
| Kadimastem Ltd | -2.62 Million USD | -240.525% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -3636.847% |
| CytoDyn Inc. | -18.02 Million USD | 50.432% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -11208.089% |
| Mobile Lads Corp. | -2.24 Million USD | -298.752% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -72977.684% |
| Qrons Inc. | -40.08 Thousand USD | -22196.525% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -1740.04% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 1794.371% |
| Rebus Holdings, Inc. | -951 Thousand USD | -839.713% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -741.486% |
| International Stem Cell Corporation | 202 Thousand USD | 4524.094% |
| Bioxytran, Inc. | -3.82 Million USD | -133.935% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -16876.957% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -262.994% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 75.085% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -19759.267% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -226.394% |
| Neutra Corp. | -181.24 Thousand USD | -4830.658% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 55.669% |
| PureTech Health plc | -11.62 Million USD | 23.139% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 55.666% |
| IXICO plc | -707 Thousand USD | -1164.027% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -16.287% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 81.515% |
| CSL Limited | 4.73 Billion USD | 100.189% |
| Cellectis S.A. | -92.63 Million USD | 90.353% |